Aplexia Pharma Private Limited

Aplexia Pharma Private Limited - pharma in Bettiah, Bihar, India. FY 2026 financials & compliance.
CIN U74999BR2018FTC038133 Incorporated 15 May 2018 ROC Patna HQ Bettiah, Bihar, India
Active Foreign Private Limited Company pharma
Revenue · FY 2025
₹85.28 Lakh
▲ 31% YoY
Net loss · FY 2025
₹77.19 Lakh
Net margin -90.5%
EBITDA · FY 2025
-₹75.98 Lakh
EBITDA margin -89.1%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹50 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Employees · EPFO
6
Provident fund records
Directors on board
2
As per MCA filings

About Aplexia Pharma Private Limited

Data last updated:

Aplexia Pharma Private Limited is a foreign private limited company based in Bettiah, Bihar, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 15 May 2018 and has been in existence for over 8 years.

The company is registered with the Registrar of Companies (ROC), Patna, under CIN U74999BR2018FTC038133. Its GSTIN is 10AAQCA9051J1ZL (Bihar).

The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors Nita Mishra and Priyesh Ranjan Pandey.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No:188 Charngaha Mishra Tola Khata No.86 Plot No.426 K R Road, Bettiah, Bihar, India – 845438.

As per the financials filed for FY 2025, the company reported a revenue of ₹85.28 Lakh, a growth of 31% compared to the previous year. For the same year it recorded a net loss of ₹77.19 Lakh (net margin -90.5%) and EBITDA of -₹75.98 Lakh (EBITDA margin -89.1%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 53% over five years.

The company has about 6 employees on its provident fund (EPFO) records.

Court records list 1 case involving the company, including 1 filed by the company.

Company details

CIN U74999BR2018FTC038133
Registration Number 038133
Incorporation Date 15 May 2018
ROC Patna
Listing Status Unlisted
Company Status Active

Contact details

Aplexia Pharma Private Limited's registered office is in Bettiah, Bihar. Its e-mail address is in the company report.

  • Email
  • Registered Address
    H.No:188 Charngaha Mishra Tola Khata No.86 Plot No.426 K R Road, Bettiah, Bihar, India – 845438
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Aplexia Pharma Private Limited, buy the company report.

Comprehensive company report
Aplexia Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Aplexia Pharma is trade. In detail, this covers retail trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG2Retail Trading

To see the full business activity and turnover split of Aplexia Pharma Private Limited, buy the company report.

Financials of Aplexia Pharma Private Limited

FY 2025 filings available

Aplexia Pharma Private Limited reported revenue of ₹85.28 Lakh (up 31% YoY) for FY 2025.

Revenue · FY 2025
₹85.28 Lakh ▲ 31%
Net loss · FY 2025
₹77.19 Lakh margin -90.5%
EBITDA · FY 2025
-₹75.98 Lakh margin -89.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 31%
3 years · compounded
▲ 2%
5 years · compounded
▲ 53%
EBITDA CAGR growth
1 year
▲ 11%
3 years · compounded
▼ 63%
5 years · compounded
▼ 61%

Revenue has grown at a compounded annual rate (CAGR) of 53% over five years, including 31% growth in the latest year. EBITDA rose 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹75.98 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹77.19 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-89.1%
Net Profit Margin-90.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Aplexia Pharma Private Limited, buy the company report.

Board of directors of Aplexia Pharma Private Limited

Aplexia Pharma has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Nita MishraDirector15 May 20188 Years 6 MonthsCurrent
Priyesh Ranjan PandeyDirector15 May 20188 Years 6 MonthsCurrent

Peer comparison

Aplexia Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Mikromart E-Commerce Private Limited₹85.34 Lakh (FY 2022)217.0%Ernakulam, Kerala, India
Frameworkz Projects and Management Services Private Limited₹85.34 Lakh (FY 2019)-17.0%Mumbai, Maharashtra, India
Jetcord India Private Limited₹85.31 Lakh (FY 2025)5.0%New Delhi, Delhi, India
Nirva Complete Sport Solutions Private Limited₹85.31 Lakh (FY 2023)14829.0%Thrissur, Kerala, India
Prime Preventives Private Limited₹85.3 Lakh (FY 2025)4.0%Patna, Bihar, India
Aplexia Pharma Private Limitedthis company₹85.28 Lakh (FY 2025)-₹77.19 Lakh-90.5%31.0%6Bettiah, Bihar, India
Parthakusuma Impex Private Limited₹85.25 Lakh (FY 2016)Secunderabad, Telangana, India
Apolo Scale Industries Private Limited₹85.21 Lakh (FY 2024)12181.0%Agra, Uttar Pradesh, India
VC Great Private Limited₹85.19 Lakh (FY 2024)-86.0%Delhi, India
TBK Shree Ganesh Traders Private Limited₹85.17 Lakh (FY 2021)-49.0%Bathinda, Punjab, India
Brandberry Marcom Private Limited₹85.17 Lakh (FY 2024)-15.0%Noida, Uttar Pradesh, India

To see the full peer comparison of Aplexia Pharma Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Aplexia Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Aplexia Pharma Private Limited has a workforce of 6 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
6
Active EPFO establishments
1
Employee growth
-53.8%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-276
FY 2025-26
FY 2024-25

To see the full employee and EPFO history of Aplexia Pharma Private Limited, buy the company report.

GST

Aplexia Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
10AAQCA9051J1ZLBiharActive13 Jul 2018

To see the full GST registrations and return filing status of Aplexia Pharma Private Limited, buy the company report.

Recent activity

Aplexia Pharma Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Nita Mishra was appointed as Director on 15 May 2018.

AGM
Aplexia Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Aplexia Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Patna.
Appointed
Nita Mishra was appointed as Director.
Appointed
Priyesh Ranjan Pandey was appointed as Director.
Incorporation
15 May 2018
Aplexia Pharma Private Limited was registered on 15 May 2018 with Roc Patna & aged 8 years 6 months as per MCA records.

Frequently asked questions

Aplexia Pharma is an active foreign private limited company based in Bettiah, Bihar, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 15 May 2018 (8+ years old) and is registered under CIN U74999BR2018FTC038133.

Aplexia Pharma has 2 current directors:

The latest financial statements of Aplexia Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.

The GSTIN of Aplexia Pharma is 10AAQCA9051J1ZL, registered in Bihar.

The CIN (Corporate Identification Number) of Aplexia Pharma is U74999BR2018FTC038133. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Aplexia Pharma has 1 court case on record: 1 filed by the company.

Aplexia Pharma was incorporated on 15 May 2018, making it 8+ years old. It is registered with the Registrar of Companies, Patna.

The peers of Aplexia Pharma by revenue are Mikromart E-Commerce Private Limited, Frameworkz Projects and Management Services Private Limited, Jetcord India Private Limited, Nirva Complete Sport Solutions Private Limited, Prime Preventives Private Limited and 5 more, all in the same principal business activity (retail trading).

Nita Mishra was appointed as Director on 15 May 2018. Priyesh Ranjan Pandey was appointed as Director on 15 May 2018.

The registered office of Aplexia Pharma is at H.No:188 Charngaha Mishra Tola Khata No.86 Plot No.426 K R Road, Bettiah, Bihar, India – 845438.

Aplexia Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.